Acetylcholinesterase inhibitors (AChEIs), a group of drugs that stimulate the AChRs by inhibiting the action of acetylcholinesterase and increasing the level of intrasynaptic acetylcholine, are now widely used in the treatment of AD (Pepeu and Giovannini, 2009). This evidence concerns the gene ACHE and Alzheimer disease.